NICE says yes to Braftovi combination for colorectal cancer
Has the Clock Struck Midnight for This Cinderella Coronavirus Stock?
WHO Officially Counsels Against Prescribing Gilead's Remdesivir To Treat COVID-19
FDA Grants EUA to Combination of Olumiant and Remdesivir in Hospitalized Covid-19 Patients
Peter Schiff: We've Sold Our Monetary Souls To The Devil
Plastic film used to protect foods and surfaces inactivates novel coronavirus
Billionaire Ken Griffin Bets on These 3 “Strong Buy” Stocks
Top Value Creation Play In Biocare
AstraZeneca and Oxford’s Covid-19 Vaccine Shows Promise in Elderly Adults
UPDATED: Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as Peter Thiel jumps on the board and IPO rumors heat up
Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
Markowski: Premature Vaccine Rally To Soon Fizzle!
Encouraging data from AZ/Oxford coronavirus shot
BioNTech says vaccine approval possible in mid-December under ideal conditions
Don’t Discount This Coronavirus Stock Just Yet, Says Analyst
Pfizer In Regular Contact With Biden Campaign, Expects To Seek Vaccine Emergency Approval Friday
FDA approves first Covid-19 test kit for home use
US Sees Most COVID Deaths Since Spring, FDA Approves Rapid Home Test: Live Updates
How mRNA vaccines from Pfizer and Moderna work, why they're a breakthrough and why they need to be kept so cold
Pfizer prepares to file COVID-19 shot after reaching safety milestone
Macro Briefing: 18 November 2020
Sanofi Wins FDA Priority Review For Enzyme Therapy; Street Bullish
J&J Targets Data For Covid-19 Vaccine US Authorization By February - Report
Superior Covid-19 Vaccine Makes Moderna Stock a Buy, Say Analysts
CBD sales are soaring, but evidence is still slim that the cannabis derivative makes a difference for anxiety or pain
CBD sales soaring, but evidence still slim that the cannabis derivative makes a difference for anxiety or pain
FDA to make emergency use authorization data public for Covid-19 vaccines
U.S. hospitals to restrict Lilly Covid-19 antibody treatment due to limited supply
Covid-19 roundup: EU begins reviewing Moderna vaccine; CureVac and EU agree to 405M-dose deal
Covid-19 roundup: CureVac and EU agree to 405M-dose deal; WHO warns that vaccine news is no panacea